FNCH

Finch Therapeutics (FNCH)

Finch Therapeutics Group Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FNCH

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/24	19:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FNCH	Finch Therapeutics Group Inc
2024/05/18	05:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FNCH	Finch Therapeutics Group Inc
2024/05/11	05:45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FNCH	Finch Therapeutics Group Inc
2024/02/24	06:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/12/14	07:20	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/11/18	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/11/08	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/08/11	19:31	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/08/10	19:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/07/08	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/29	05:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/29	05:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/24	05:31	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/10	06:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/10	05:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/10	05:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/10	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/10	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/10	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/06/09	20:00	GlobeNewswire Inc.	Finch Announces Reverse Stock Split of Common Stock	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/05/31	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/05/19	05:15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/05/17	05:17	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/05/12	05:13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/05/12	05:05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/05/10	20:15	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/05/10	20:13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/05/10	20:00	GlobeNewswire Inc.	Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/04/27	05:05	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:FNCH	Finch Therapeutics Group Inc
2023/04/27	05:03	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:FNCH	Finch Therapeutics Group Inc